Activity of botulinum neurotoxin X and its structure when shielded by a non-toxic non-hemagglutinin protein.
JSON
Martínez-Carranza M, Škerlová J, Lee PG, Zhang J, Krč A, Sirohiwal A, Burgin D, Elliott M, Philippe J, Donald S, Hornby F, Henriksson L, Masuyer G, Kaila VRI, Beard M, Dong M, Stenmark P
Commun Chem 7 (1) 179 [2024-08-13; online 2024-08-13]
Botulinum neurotoxins (BoNTs) are the most potent toxins known and are used to treat an increasing number of medical disorders. All BoNTs are naturally co-expressed with a protective partner protein (NTNH) with which they form a 300 kDa complex, to resist acidic and proteolytic attack from the digestive tract. We have previously identified a new botulinum neurotoxin serotype, BoNT/X, that has unique and therapeutically attractive properties. We present the cryo-EM structure of the BoNT/X-NTNH/X complex and the crystal structure of the isolated NTNH protein. Unexpectedly, the BoNT/X complex is stable and protease-resistant at both neutral and acidic pH and disassembles only in alkaline conditions. Using the stabilizing effect of NTNH, we isolated BoNT/X and showed that it has very low potency both in vitro and in vivo. Given the high catalytic activity and translocation efficacy of BoNT/X, low activity of the full toxin is likely due to the receptor-binding domain, which presents very weak ganglioside binding and exposed hydrophobic surfaces.
PubMed 39138288
DOI 10.1038/s42004-024-01262-8
Crossref 10.1038/s42004-024-01262-8
pmc: PMC11322297
pii: 10.1038/s42004-024-01262-8